PEP-Therapy
PrivateLast Round
Series A
Extension
Jul 19, 2021
Total Funding Raised
$11.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PEP-Therapy operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A Extension round in July 2021.
PEP-Therapy is a biotechnology company that develops first-in-class peptide-based targeted therapies for oncology using an intracellular drug delivery shuttle.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PEP-Therapy Comparables
Compare PEP-Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 84% | |
| Cybrexa Therapeutics | 82% | |
| APIM Therapeutics AS | 82% |
For institutional investors. Book with your work email.
PEP-Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 19, 2021 | ||||
| Series A | Apr 22, 2021 | ||||
| Grant | Apr 17, 2018 | ||||
| Seed | Apr 27, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PEP-Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anaxago | Series A Extension |
| Bpifrance | Series A Extension |
| Business Angels des Grandes Ecoles | Series A Extension, Series A |
| Seventure Partners | Series A |
| i&i Prague | Series A Extension |
| Doorway | Series A |
| Italian Angels for Growth | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 474% MoM.
- Apr 6, 2026
Monthly visitors increased 159% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
PEP-Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PEP-Therapy's valuation, stock price, and market status.
Is PEP-Therapy a public or private company?
PEP-Therapy is a private company.
What is the current stock price of PEP-Therapy?
PEP-Therapy is a private company, so its shares have no public market price. Caplight tracks PEP-Therapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PEP-Therapy worth (valuation)?
Valuation information for PEP-Therapy is not publicly available.
Can I buy PEP-Therapy stock?
PEP-Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PEP-Therapy's last funding round?
PEP-Therapy's most recent funding round was Series A Extension on July 19, 2021.
Who are the main investors in PEP-Therapy?
Key investors in PEP-Therapy include Italian Angels for Growth.
Will PEP-Therapy IPO soon?
No public IPO plans have been announced for PEP-Therapy.
How can I track PEP-Therapy secondary market activity?
Caplight tracks bids, offers, and trades in PEP-Therapy's shares on secondary markets.